Schedule 13G ownership disclosure
ADVERUM BIOTECHNOLOGIES INC
Security class unavailable · CUSIP: 00773U108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,455,848
- Percent of class
- 2.2500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001037389-20-000303
- Form type
- SC 13G
- Filer
- Adverum Biotechnologies, Inc.
- CIK
- CIK 1501756
- Filed
- Feb 13, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership